Long-term clinical studies of drug-eluting stents (DES) have reported high incidence of late
thrombosis. Given the growing concern over the clinical application of this technology, we …

Following stent implantation and vascular injury, restenosis is one of the prominent clinical
problems due to the synergism effects of inflammatory cytokines and growth factors …

Drug-eluting stents (DES), which release anti-proliferative drugs into the arterial wall in a
controlled manner, have drastically reduced the rate of in-stent restenosis and …

Drug-eluting stents (DES) have a major role in treating cardiovascular disease. The
evolution of bare metal stents into 1 st generation durable-polymer DES (DP-DES) reduced …

To investigate phenotypic and genotypic alterations before and after bone metastasis, we
conducted genome-wide mRNA profiling and DNA exon sequencing of two cell lines (TMD …

Despite our increasing understanding of zebrafish heart development and regeneration,
there is limited information about the distribution of endothelial cells (ECs) in the adult …

Anticancer drugs are commonly used as inhibitors of vascular smooth muscle cell (VSMC)
proliferation in clinical treatments. This study aims to investigate how elemene affects the …

Ruthenium (II) trisdiimine complexes of the formula,[Ru (dip) n (L− L) 3‐n] 2+, where n= 0‐3;
dip= 4, 7‐diphenyl‐1, 10‐phenanthroline; L–L= 2, 2'‐bipyridine (bpy) or 1, 10 …

Objective Excessive neointima formation often occurs after arterial injury. Interleukin-1β (IL-
1β) is a potent pleiotropic cytokine that has been shown to regulate neointimal proliferation …

Excessive proliferation and migration of vascular smooth muscle cells (VSMCs) and delayed
proliferation and migration of endothelial cells (ECs) were the main cause of restenosis after …